For which antilipemic medication should the nurse question an order in a patient with liver cirrhosis?

The medication that should be questioned in a patient with liver cirrhosis is atorvastatin (Lipitor). Statins, such as atorvastatin, are primarily metabolized in the liver, and their use can significantly impact liver function. In patients with liver cirrhosis, the liver's ability to process and eliminate the medication may be compromised, leading to an increased risk of toxicity and adverse effects.

Since atorvastatin can raise liver enzyme levels and has potential hepatotoxic effects, it is recommended to approach its use with caution in patients with liver diseases. Additionally, atorvastatin may exacerbate the existing liver condition due to increased strain on liver metabolism.

In contrast, niacin, ezetimibe, and gemfibrozil may have different implications, but atorvastatin's specific metabolism and effects on liver function make it particularly concerning for patients with liver cirrhosis. Managing cholesterol levels in such patients often requires alternative therapies that have a safer profile regarding liver health.